Cite
HARVARD Citation
Momotow, J. et al. (2022). Outcomes of anti‐programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real‐world analysis. British journal of haematology. pp. 401-404. [Online].